8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Edwards Lifesciences Corp (EW)

Edwards Lifesciences ($EW) issued a press release on Feb 10, 2026 reporting Q4 2025 financial results; the…

Filed with the SEC on · Summarized by InvestorsBot

Edwards Lifesciences ($EW) issued a press release on Feb 10, 2026 reporting Q4 2025 financial results; the release is furnished as Exhibit 99.1 to Form 8‑K. 📢📄 #Earnings #Healthcare #8K

Exhibit 99.1 is furnished — not “filed” — under the Securities Exchange Act. Investors should review the Feb 10 press release for full Q4 2025 metrics. $EW 🔍 #Earnings #8K #Healthcare

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Edwards Lifesciences Corp

Edwards Lifesciences Raises 2026 Guidance After 13.6% Q2 Sales Growth

8-K · July 23, 2026

Edwards filed an 8‑K (Item 9.01) on Feb 10, 2026: Exhibit 99.1 is a press release reporting Q4 2025…

8-K · February 10, 2026

Edwards Lifesciences filed an 8‑K (Item 9.01) on Jan 12, 2026 — Exhibit 99.1: Press Release dated Jan 9,…

8-K · January 12, 2026

Jan 9, 2026 — U.S.

8-K · January 12, 2026